Education
About Us
Working with TipRanks
Follow Us
Plandai Biotechnology Inc (PLPL)
OTHER OTC:PLPL
Total Valuation
Plandai Biotechnology has a market cap or net worth of $7.75K. The enterprise value is ―.
Market Cap$7.75K
Enterprise Value―
Share Statistics
Plandai Biotechnology has 7,749,662,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,749,662,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Plandai Biotechnology’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee89.05K
Employee Count180
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Plandai Biotechnology is ―. Plandai Biotechnology’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Plandai Biotechnology had revenue of 0.00 and earned 16.03M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-3.81M
Pretax Income16.03M
Net Income16.03M
EBITDA16.03M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 15.81M and capital expenditures 0.00, giving a free cash flow of 15.81M billion.
Operating Cash Flow15.81M
Free Cash Flow15.81M
Free Cash Flow per Share<0.01
Dividends & Yields
Plandai Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-118.37
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)1.66M
Important Dates
Plandai Biotechnology upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Plandai Biotechnology as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Plandai Biotechnology has paid 16.03M in taxes.
Income Tax16.03M
Effective Tax Rate―
Enterprise Valuation
Plandai Biotechnology EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Plandai Biotechnology has $0.00 in cash and marketable securities with $155.00K in debt, giving a net cash position of $155.00K billion.
Cash & Marketable Securities$0.00
Total Debt$155.00K
Net Cash$155.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Plandai Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―